UNPRI

PAAMC HK Announces Winning in ESG Leading Enterprise Awards 2022

Retrieved on: 
Mercredi, décembre 14, 2022

HONG KONG, Dec. 14, 2022 /PRNewswire/ -- Ping An of China Asset Management (Hong Kong) Company Limited ("PAAMC HK" or "Company"), the offshore asset management arm of the Ping An Insurance (Group) Company of China, Ltd. ("Ping An"), announced that it has been honoured that the Company has been honored with the ESG Leading Enterprise Awards 2022, recognized in the category of "ESG Investing".

Key Points: 
  • HONG KONG, Dec. 14, 2022 /PRNewswire/ -- Ping An of China Asset Management (Hong Kong) Company Limited ("PAAMC HK" or "Company"), the offshore asset management arm of the Ping An Insurance (Group) Company of China, Ltd. ("Ping An"), announced that it has been honoured that the Company has been honored with the ESG Leading Enterprise Awards 2022, recognized in the category of "ESG Investing".
  • As a pioneer embodying Ping An's ESG strategy in its business activities overseas, PAAMC HK is committed to promote ESG and green investments in China and globally mobilizing capital to reduce carbon footprint.
  • Jointly presented by the Chinese Edition of Bloomberg Businessweek andDeloitte, the fourth ESG Leading Enterprise Awards announced and honored the winners on December 12.
  • [i] Source: Morgan Stanley Capital Investment's (MSCI) 2022 ESG Ratings, as of November 2022.

Apple's Woes in China Expose the Hypocrisy of ESG as a Risk Assessment Tool says Friends of Science Society

Retrieved on: 
Jeudi, décembre 1, 2022

CALGARY, Alberta, Dec. 1, 2022 /PRNewswire-PRWeb/ -- (Calgary, Alberta) Parts of China have been rocked by vehement protests in recent days, specifically at the Apple contractor Foxconn complex, as reported by CNN, Nov. 24, 2022, the details of which expose the hypocrisy of "ESG" reporting and corporate evaluation, says Friends of Science Society.

Key Points: 
  • As protests erupt at Apple's Foxconn production facility in China, the hypocrisy of 'environment, social, governance' (ESG) accounting is exposed, says Friends of Science Society.
  • "The current defense du jour of ESG is that it's not a politicized investment strategy but, rather, a simple risk-assessment tool.
  • The UN HLEG "Integrity Matters" report, proposing dictatorial mandatory NetZero reporting poses a risk to society , says Friends of Science.
  • Friends of Science Society is an independent group of earth, atmospheric and solar scientists, engineers, and citizens that is celebrating its 20th year of offering climate science insights.

Golding Capital Partners GmbH: Golding study: funds of funds reduce volatility in private markets by 90 per cent

Retrieved on: 
Mercredi, novembre 30, 2022

The significant advantage of up to 90 per cent for risk diversification by means of funds of funds is confirmed for the buyout asset class and fundamentally also for infrastructure and private credit.

Key Points: 
  • The significant advantage of up to 90 per cent for risk diversification by means of funds of funds is confirmed for the buyout asset class and fundamentally also for infrastructure and private credit.
  • By exactly how much do funds of funds reduce investors risk of loss, especially in private markets?
  • And indeed, in all three cases we can definitely recommend the vast majority of investors to diversify via funds of funds.
  • By contrast, the worst five per cent of funds of funds still generated a positive multiple of up to 1.15.

EQS-News: Golding Capital Partners GmbH: Golding study: funds of funds reduce volatility in private markets by 90 per cent

Retrieved on: 
Mercredi, novembre 30, 2022

The significant advantage of up to 90 per cent for risk diversification by means of funds of funds is confirmed for the buyout asset class and fundamentally also for infrastructure and private credit.

Key Points: 
  • The significant advantage of up to 90 per cent for risk diversification by means of funds of funds is confirmed for the buyout asset class and fundamentally also for infrastructure and private credit.
  • By exactly how much do funds of funds reduce investors risk of loss, especially in private markets?
  • And indeed, in all three cases we can definitely recommend the vast majority of investors to diversify via funds of funds.
  • By contrast, the worst five per cent of funds of funds still generated a positive multiple of up to 1.15.

EQS-News: Golding Capital Partners GmbH: Golding raises €75 million at the first closing of its début private debt co-investment fund

Retrieved on: 
Dimanche, novembre 27, 2022

Munich, 15th November 2022 Golding Capital Partners has received capital commitments of 75 million at the first closing of its inaugural dedicated co-investment fund in the private credit asset class.

Key Points: 
  • Munich, 15th November 2022 Golding Capital Partners has received capital commitments of 75 million at the first closing of its inaugural dedicated co-investment fund in the private credit asset class.
  • Experienced existing investors seized the opportunity offered by the initial fundraising phase to subscribe for Golding Private Debt Co-Investment 2021, which has a target volume of 200 million.
  • Golding Private Debt Co-Investment 2021 gives institutional investors access to the breadth of the European direct lending market.
  • The fund Golding Private Debt Co-Investment 2021 is structured as a Luxembourg SCS SICAV-FIAR and has a lifetime of eight years.

SEMCAP Announces First Annual Impact Report and Adoption of Formal ESG Framework

Retrieved on: 
Mardi, novembre 15, 2022

As seasoned investors, weve spent many years investing in and building companies that transform industries and change the way business is conducted.

Key Points: 
  • As seasoned investors, weve spent many years investing in and building companies that transform industries and change the way business is conducted.
  • In launching SEMCAP, we resolved to expand on those efforts to build valuable companies with the greatest potential impact on humanity and the environment, said Walter Buck Buckley, co-founder and co-CIO at SEMCAP.
  • SEMCAP will continue to challenge its team and portfolio companies across its three verticals to lead the change needed.
  • Importantly, SEMCAP is also committed to ensuring the firms internal practices and culture align with its social and environmental values.

Golding Raises €75 Million at the First Closing of its Début Private Debt Co-investment Fund

Retrieved on: 
Mardi, novembre 15, 2022

Golding Capital Partners has received capital commitments of 75 million at the first closing of its inaugural dedicated co-investment fund in the private credit asset class.

Key Points: 
  • Golding Capital Partners has received capital commitments of 75 million at the first closing of its inaugural dedicated co-investment fund in the private credit asset class.
  • Experienced existing investors seized the opportunity offered by the initial fundraising phase to subscribe for Golding Private Debt Co-Investment 2021, which has a target volume of 200 million.
  • Golding Private Debt Co-Investment 2021 gives institutional investors access to the breadth of the European direct lending market.
  • The fund Golding Private Debt Co-Investment 2021 is structured as a Luxembourg SCS SICAV-FIAR and has a lifetime of eight years.

Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq

Retrieved on: 
Dimanche, novembre 13, 2022

HONG KONG, Nov 13, 2022 - (ACN Newswire) - On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited ("Atour") was officially listed on the Nasdaq Stock Exchange in the United States.

Key Points: 
  • HONG KONG, Nov 13, 2022 - (ACN Newswire) - On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited ("Atour") was officially listed on the Nasdaq Stock Exchange in the United States.
  • Founded in 2013, Atour is a leading hospitality and lifestyle company in China with a distinct portfolio of lifestyle hotel brands, such as A.T. HOUSE, Atour S, ZHOTEL, Atour Hotel, Atour X and Atour Light, as well as scenario-based retail brands, including Atour Market.
  • As an important institutional investor and close partner of Atour, Legend Capital led the investment in Atour in 2016, and continued to make additional investments in Atour's subsequent financing rounds in 2017 and 2021.
  • Legend Capital said: " The past nine years have witnessed Atour's continuous development since its first hotel opening in 2013.

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

Retrieved on: 
Jeudi, novembre 10, 2022

HONG KONG, Nov 10, 2022 - (ACN Newswire) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.

Key Points: 
  • HONG KONG, Nov 10, 2022 - (ACN Newswire) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.
  • The company's service network has spread to 10 countries and regions worldwide, including the United States, Germany, Italy, Spain, Switzerland and Poland.
  • Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add.
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

Legend Capital Portfolio Company Giant Biogene Successfully Lists on the HKEX

Retrieved on: 
Lundi, novembre 7, 2022

HONG KONG, Nov 7, 2022 - (ACN Newswire) - On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange.

Key Points: 
  • HONG KONG, Nov 7, 2022 - (ACN Newswire) - On November 4, 2022, Legend Capital portfolio company Giant Biogene (2367.HK) was successfully listed on the main board of the Hong Kong Stock Exchange.
  • Richard LI, President of Legend Capital, said: "Congratulations to Giant Biogene on its successful listing on the main board of the Hong Kong Stock Exchange.
  • Legend Capital is very honored to be an investor in Giant Biogene and to carry out in-depth investment cooperation with the company.
  • Tony WANG, Managing Director of Legend Capital, said: "Giant Biogene is a pioneer in the synthetic biology industry.